adalimumab-aaty

CHEBI:CHEBI_746971

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2668487
brand_name
Adalimumab
brand_name_base
Adalimumab
pharm_class
Monoclonal [CS]
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
dosage_form
INJECTION
route
SUBCUTANEOUS
marketing_start_date
20231130
package_marketing_start_date
20231130
marketing_category
BLA
active_ingredient_strength
20 mg/.2mL
active_ingredient_name
ADALIMUMAB
unii
FYS6T7F842
nui
M0001357
pharm_class_epc
Tumor Necrosis Factor Blocker [EPC]
pharm_class_moa
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
pharm_class_cs
Antibodies, Monoclonal [CS]
generic_name
adalimumab-aaty
product_ndc
72606-041
application_number
BLA761219
labeler_name
CELLTRION USA, Inc.
manufacturer_name
CELLTRION USA, Inc.
spl_id
844d5d61-baed-44ee-afc2-5dd8174c54ca
package_ndc
72606-041-01
package_description
2 SYRINGE, GLASS in 1 CARTON (72606-041-01) / .2 mL in 1 SYRINGE, GLASS
spl_set_id
c44365e9-d470-4e35-978d-8565a9e3471e
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class